分享此文章： Share on Email Share on Line Share on Facebook Copy to Clipboard Previous Post GlycoNex and PrecisemAb Co-Develop an Innovative Pro-Antibody Demonstrating High Tumor Selectivity and Safety; Research Published in an International Journal Next Post PrecisemAb Breaks Into the Final Six and Secures the Company First Prize at the 9th Startup Star Competition
Get In Touch We can't wait to hear from you！ Contact Us +886 7 311 1577 ｜Taipei office｜ 17F, No. 3, Park St., Nangang Dist., Taipei City 115, Taiwan Kaohsiung office｜ 12F, 1st Teaching Building, 100, Shih-Chuan 1st Rd., Sanmin Dist., Kaohsiung 807, Taiwan Home About Technical Capabilities Pipeline Antibody LockTM Platform News Partner & Investor Contact Stay Connected If you see this, Happy New Year! If you see this, Happy New Year!
